RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2

To identify molecular targets that modify sensitivity to lenalidomide, we measured proliferation in multiple myeloma (MM) cells transfected with 27 968 small interfering RNAs in the presence of increasing concentrations of drug and identified 63 genes that enhance activity of lenalidomide upon silen...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood
Asıl Yazarlar: Zhu, Yuan Xiao, Yin, Hongwei, Bruins, Laura A., Shi, Chang-Xin, Jedlowski, Patrick, Aziz, Meraj, Sereduk, Chris, Kortuem, Klaus Martin, Schmidt, Jessica E., Champion, Mia, Braggio, Esteban, Keith Stewart, A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2015
Konular:
Lymphoid Neoplasia
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4296009/
https://ncbi.nlm.nih.gov/pubmed/25395420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-05-577130
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller